Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

WhiteRock Capital Partners update

14 Aug 2013 07:00

RNS Number : 6256L
Braveheart Investment Group plc
14 August 2013
 



 

14 August 2013

WhiteRock Capital Partners update

Braveheart Investment Group plc (the 'Group' or the 'Company') (BRH), the AIM-listed investment management group providing debt/equity and advisory services to SMEs and servicing the investment requirements of business angels, high net worth individuals, family offices, and public sector organisations, is pleased to announce that the ÂŁ50 million Northern Ireland Growth Loan Fund ('GLF', 'Growth Loan Fund') has, to date, approved 40 loans, totalling more than ÂŁ10 million.

WhiteRock Capital Partners LLP, which provides mezzanine finance to established Northern Ireland SMEs seeking access to growth finance, was established in 2012 by the Group, and consortium partners Clarendon Fund Managers Ltd and NEL Fund Managers Ltd, to manage the Growth Loan Fund.

Some of the larger loans include ÂŁ500,000 to MSO Cleland, an East Belfast-based designer and manufacturer of printed carton packaging; and ÂŁ500,000 to Domestic Sheepskins, a Co Armagh company providing treated skins and hides for use in fashion, accessories and upholstery.

WhiteRock Capital Partners was recognised for its achievements at the Northern Ireland Insider Media Dealmakers Award in April 2013 with the award for Private Equity Firm of the Year.

 

Further information:

Braveheart Investment Group plc

Geoffrey Thomson, Chief Executive Tel: 01738 587555

gthomson@braveheartgroup.co.uk

 

Sanlam Securities UK Limited (Nominated Advisor and Broker to Braveheart)

Lindsay Mair Tel: 020 7628 2200

Catherine Miles

 

WhiteRock Capital Partners LLP

Paul Millar Tel: 028 9500 1060

paulmillar@whiterockcp.co.uk

 

Media Enquiries:

Allerton Communications

Peter Curtain Tel: 020 3137 2500

peter.curtain@allertoncomms.co.uk

 

Notes to Editors

 

Braveheart Investment Group plc

 

Braveheart provides financing and associated advisory services for small and medium sized enterprises (SMEs) as follows:

 

For the company looking to raise money, we provide:

· Equity Capital. This form of financing is typically long term and is usually appropriate for fast growing business or early stage companies. We will consider equity financings where our individual investment, or the investment we arrange, would normally be a maximum of £2m although we are happy to participate in larger financings as part of a syndicate;

· Debt Finance. Short to medium term and for companies with cash flow to service the loan. Out unit size for this type of finance is up to £1m and we will usually provide junior debt which is unsecured but linked to an equity instrument;

· Corporate finance advice on all aspects of raising money, strategic development and corporate governance.

 

The money we invest comes from a variety of sources (see below) and is sometimes linked to particular geographical locations.

 

To the investor, we provide a one-stop shop service to those in one of the following groups who are looking for exposure to SME investments:

· High net worth (HNW) individuals looking to build tax efficient Enterprise Investment Scheme (EIS) and Seed EIS portfolios;

· Family offices and private sector institutions;

· The Public sector.

Investors can choose between investment types ranging from self-build portfolios, to a full fund management service.

 

www.braveheartgroup.co.uk

 

WhiteRock Capital Partners LLP

WhiteRock Capital Partners LLP was established in 2012 by Braveheart Investment Group and consortium partners NEL Fund Managers and Clarendon Fund Managers to manage the Northern Ireland Growth Loan Fund.

The Growth Loan Fund provides loans, primarily unsecured in nature, of between ÂŁ50,000 and ÂŁ500,000 to Small and Medium Enterprises (SMEs). Loans are made to businesses that can demonstrate sales and profitability growth or growth potential. The Fund targets businesses with export potential, active mainly in the manufacturing, engineering or tradable services sectors.

The Fund is run on a fully commercial basis. Finance for the Fund has been provided by Invest NI (ÂŁ25m) with additional finance provided by the private sector.

www.whiterockcp.co.uk

 

Growth Loan Fund

 

Finance for the ÂŁ50m Growth Loan Fund - which provides mezzanine finance to established Northern Ireland SMEs seeking access to growth finance - has been provided by Invest Northern Ireland and private investor, Northern Ireland Local Government Officer's Superannuation Committee (NILGOSC). WhiteRock Capital Partners LLP has been established to respond to enquiries to the Fund by the consortium of three partners - Strathtay Ventures Limited, a wholly owned subsidiary of Braveheart Investment Group; NEL Fund Managers; and Clarendon Fund Managers; all of which are authorised and regulated by the FCA. Companies seeking funding from the Growth Loan Fund must be based in Northern Ireland, demonstrating growth potential and generally be in the manufacturing, engineering or tradable services sectors. Loan will be typically unsecured and personal guarantees will not be sought. The loans provided are expected to be complimentary to existing sources of finance, including banks, trade finance sources and equity investors. Loans are provided on a fully commercial basis, with monthly loan repayments required over typically a five-year term.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASFMFMDFDSEFA
Date   Source Headline
10th Oct 20251:20 pmRNSConfirmation of change of name and website
26th Sep 20257:00 amRNSProposed Change of Name
9th Sep 20257:00 amRNSBlock admission six monthly return
2nd Sep 202511:23 amRNSHolding(s) in Company
1st Aug 20253:04 pmRNSResult of AGM
9th Jul 20252:41 pmRNSFinal Results and Notice of AGM
30th May 20255:00 pmRNSTotal Voting Rights
27th May 20253:15 pmRNSHolding(s) in Company
21st May 20257:00 amRNSResult of Broker Option and Total Voting Rights
16th May 20252:08 pmRNSPlacing to raise £135,000
14th May 202511:55 amRNSHolding(s) in Company
18th Mar 202510:30 amRNSSubscription in IQ-AI Ltd Placing
6th Mar 202510:03 amRNSBlock admission six monthly return
3rd Feb 20257:00 amRNSCancellation of options
20th Jan 20255:32 pmRNSDirector/PDMR Shareholding - acquisition of shares
14th Jan 202511:15 amRNSHolding(s) in Company
8th Jan 20254:54 pmRNSChange of Auditor
10th Dec 20241:28 pmRNSDirector/PDMR Shareholding
9th Dec 202412:16 pmRNSDirector/PDMR Shareholding - acquisition of shares
2nd Dec 20244:22 pmRNSHolding(s) in Company
2nd Dec 20249:05 amRNSDirector/PDMR Shareholding
7th Nov 202411:10 amRNSHolding(s) in Company
7th Nov 202411:06 amRNSDirector/PDMR Shareholding - acquisition of shares
15th Oct 202410:28 amRNSHolding(s) in Company
15th Oct 20247:00 amRNSHalf-year Report
11th Oct 202410:00 amRNSInvestment in IQ-AI Limited and RPT
26th Sep 20249:35 amRNSAppointment of representative to Board of Autins
9th Sep 202410:15 amRNSBlock admission six monthly return
4th Sep 20247:00 amRNSHolding(s) in Company
20th Aug 20245:15 pmRNSHolding(s) in Company
7th Aug 20247:00 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSAcquisition of interest in Image Scan Holdings plc
6th Aug 20245:30 pmRNSHolding(s) in Company
1st Aug 20247:00 amRNSInvestment update – Gyrometric
24th Jul 20247:00 amRNSInvestment update - Kirkstall and Paraytec
24th Jul 20247:00 amRNSHolding(s) in Company
18th Jul 20242:23 pmRNSResult of AGM
15th Jul 20244:27 pmRNSGrant of options
26th Jun 20242:03 pmRNSAcquisition of further interest in Autins Group
21st Jun 20247:00 amRNSFinal Results and Notice of AGM
15th May 202411:22 amRNSRevaluation of portfolio assets
29th Apr 20242:07 pmRNSHolding(s) in Company
29th Apr 20241:42 pmRNSBlock admission six monthly return
10th Apr 20247:00 amRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSAcquisition of further interest in Autins Group
4th Mar 202411:48 amRNSInvestment update – Paraytec Limited
4th Mar 20247:00 amRNSCompletion of sale of Phasefocus
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.